PET Imaging

Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.

Technology

October 5, 2012 — Imagine a place where doctors can tell patients in advance if cancer treatment will work for them ...

Time October 05, 2012
arrow
News

October 3, 2012 — The National Institutes of Health (NIH)/National Cancer Institute (NCI) has awarded a five-year ...

Time October 03, 2012
arrow
Technology

September 14, 2012 — The U.S. Food and Drug Administration (FDA) has approved the production and use of Choline C-11 ...

Time September 14, 2012
arrow
News

September 12, 2012 – Positron Corp. announced that Jubilant DraxImage Inc., a Jubilant Life Sciences company, and ...

Time September 12, 2012
arrow
Blog

We want absolutes; things we can depend on; certainties in an unfortunately uncertain world. It’s the kind of faith we ...

Time August 29, 2012
arrow
Feature

August 27, 2012 — The growth rate of positron emission tomography (PET) and PET/computed tomography (CT) medical imaging ...

Time August 27, 2012
arrow
Feature

August 27, 2012 — Positron Corp., a molecular imaging healthcare company, announced the submission of a drug master file ...

Time August 27, 2012
arrow
Feature

August 24, 2012 — West Physics Consulting, a national provider of medical and health physics consulting and testing ...

Time August 24, 2012
arrow
Technology

August 21, 2012 — Siemens Healthcare announced that its syngo.PET Amyloid Plaque proprietary software has received ...

Time August 21, 2012
arrow
Technology

August 21, 2012 — The U.S. Food and Drug Administration (FDA) granted marketing approval for cfrQuant, coronary flow ...

Time August 21, 2012
arrow
News

August 20, 2012 — Positron Corp. announced the use of its Attrius system at Caring Heart and Brain Imaging Inc. of ...

Time August 20, 2012
arrow
News

August 14, 2012 — Positron Corp. announced the transfer, consolidation and integration of its radiopharmaceutical ...

Time August 14, 2012
arrow
News

August 3, 2012 — FluoroPharma Medical Inc., a company specializing in the development of novel diagnostic imaging ...

Time August 03, 2012
arrow
Blog

When I was a kid, living in a mid-size Wisconsin town, my family would drive the mile or so from our home to the Lake ...

Time July 27, 2012
arrow
News

July 27, 2012 — Siemens Healthcare (booth 707) will be at the 2012 Annual Meeting of the American Association of ...

Time July 27, 2012
arrow
News

July 25, 2012 — Positron Corp. announced approval of a pledge for $15 million in tax increment financing (TIF) bonds ...

Time July 25, 2012
arrow
Feature | Breast Imaging | Parvez Shirazi, M.D.

The last 20 years have brought about great advances in breast cancer detection and treatment. Among them has been the ...

Time July 25, 2012
arrow
News

July 24, 2012 — Navidea Biopharmaceuticals Inc., a specialty pharmaceutical company focused on precision diagnostic ...

Time July 24, 2012
arrow
News

July 23, 2012 — GE Healthcare announced the final results from a Phase III study of the investigational PET (positron ...

Time July 23, 2012
arrow
News

July 13, 2012 — Royal Philips Electronics announced that it has embarked on a five-year joint research and development ...

Time July 13, 2012
arrow
Subscribe Now